New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Columbia neuroscientists have identified brain-cell circuitry in fruit flies that converts waves of light entering the eye into color perceptions in the brain.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
A study co-led by Columbia scientists suggests a nutrient transporter located at the blood-brain barrier could be commandeered to sneak therapeutic drugs into the brain.
The Carol and Gene Ludwig Center for Research on Neurodegeneration will bring novel approaches to Alzheimer’s and other neurodegenerative disease research.
Columbia neuroscientists have discovered that the brain has greater control over the motor neurons that move the body than previously thought possible.
Models that perform statistical analyses of hundreds of visual clues point the way to understanding how our brains give us the ability to distinguish faces.
A gene called FMNL2 may explain why people with hypertension, diabetes, heart disease, or obesity have a greater risk of developing Alzheimer's disease.
Loss of smell in COVID may be caused by a dramatic rearrangement of chromosomes in the cells that connect the nose to the brain, a study by Columbia neuroscientists suggests.
Just a single type of neuron controls the complex patterns of walking, a surprising finding that may lead to new therapeutic approaches for people with spinal cord injuries.